From June 14, 2023 to June 30, 2023, the company has repurchased 1,593,128 shares, representing 2.11% for $0.89 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4504 USD | -3.08% | -5.97% | -77.92% |
14/05 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.92% | 3.35Cr | |
+23.68% | 8.7TCr | |
-23.44% | 7.56TCr | |
+0.49% | 2.7TCr | |
+5.59% | 1.79TCr | |
-12.64% | 1.66TCr | |
+3.39% | 1.57TCr | |
+77.13% | 1.3TCr | |
+79.89% | 1.29TCr | |
+37.72% | 1.26TCr |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.